Literature DB >> 29695561

Circulating microRNAs as Novel Biomarkers for Atherosclerosis.

Seda Gulec Yilmaz1, Selim Isbir2, Atike Tekeli Kunt3, Turgay Isbir4.   

Abstract

BACKGROUND/AIM: In this study, we determined the expression of selected circulating microRNAs (miRNA) and their potential roles as biomarkers in patients with atherosclerosis and a control group.
MATERIALS AND METHODS: In order to obtain insight into miRNA expression levels in atherosclerosis, we analyzed miRNA expression levels by real-time polymerase chain reaction (RT-PCR) in case (n=89) and healthy control (n=93) groups. Receiver operating characteristic curve analysis was performed to assess the diagnostic capability of miRNAs.
RESULTS: miRNA221 and miRNA221 expression levels were significantly lower in patients than controls (p=0.011 and p=0.004, respectively). Receiver operator curve analysis demonstrated that expression levels of miRNA221 [area under curve (AUC)=0.623, p=0.0086) and miRNA222 (AUC=0.654, p=0.0006) were significantly different between groups. There were positive correlations between miRNA122a and triglyceride (p=0.046) and very-low-density lipoprotein (p=0.029) levels.
CONCLUSION: miRNA221 and miRNA222 could be convenient biomarkers for diagnosis of atherosclerosis. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Atherosclerosis; biomarker; miRNA122a; miRNA221; miRNA222

Mesh:

Substances:

Year:  2018        PMID: 29695561      PMCID: PMC6000792          DOI: 10.21873/invivo.11276

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  17 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application.

Authors:  Xiaojun Liu; Yunhui Cheng; Jian Yang; Ling Xu; Chunxiang Zhang
Journal:  J Mol Cell Cardiol       Date:  2011-11-22       Impact factor: 5.000

Review 3.  MicroRNAs and atherosclerosis: new actors for an old movie.

Authors:  D Santovito; A Mezzetti; F Cipollone
Journal:  Nutr Metab Cardiovasc Dis       Date:  2012-06-28       Impact factor: 4.222

4.  MicroRNAs modulate the angiogenic properties of HUVECs.

Authors:  Laura Poliseno; Andrea Tuccoli; Laura Mariani; Monica Evangelista; Lorenzo Citti; Keith Woods; Alberto Mercatanti; Scott Hammond; Giuseppe Rainaldi
Journal:  Blood       Date:  2006-07-18       Impact factor: 22.113

5.  miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

Authors:  Jinhong Chang; Emmanuelle Nicolas; Debora Marks; Chris Sander; Anthony Lerro; Marie Annick Buendia; Chunxiao Xu; William S Mason; Thomas Moloshok; Roque Bort; Kenneth S Zaret; John M Taylor
Journal:  RNA Biol       Date:  2004-07-01       Impact factor: 4.652

Review 6.  Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction.

Authors:  Chuanwei Li; Fang Pei; Xiaoshan Zhu; Dayue D Duan; Chunyu Zeng
Journal:  Clin Biochem       Date:  2012-07       Impact factor: 3.281

7.  MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism.

Authors:  Dimitrios Iliopoulos; Konstantinos Drosatos; Yaeko Hiyama; Ira J Goldberg; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2010-02-02       Impact factor: 5.922

8.  Expression profiles of six circulating microRNAs critical to atherosclerosis in patients with subclinical hypothyroidism: a clinical study.

Authors:  Xinhuan Zhang; Shanshan Shao; Houfa Geng; Yong Yu; Chenggang Wang; Zhanfeng Liu; Chunxiao Yu; Xiuyun Jiang; Yangxin Deng; Ling Gao; Jiajun Zhao
Journal:  J Clin Endocrinol Metab       Date:  2014-02-11       Impact factor: 5.958

9.  A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia.

Authors:  Xiaojun Liu; Yunhui Cheng; Shuo Zhang; Ying Lin; Jian Yang; Chunxiang Zhang
Journal:  Circ Res       Date:  2009-01-15       Impact factor: 17.367

Review 10.  Role of microRNAs in vascular diseases, inflammation, and angiogenesis.

Authors:  Carmen Urbich; Angelika Kuehbacher; Stefanie Dimmeler
Journal:  Cardiovasc Res       Date:  2008-06-11       Impact factor: 10.787

View more
  6 in total

1.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

2.  miR-185 silencing promotes the progression of atherosclerosis via targeting stromal interaction molecule 1.

Authors:  Ming Fang; Yanfei Li; Yingbiao Wu; Zhongping Ning; Xuejun Wang; Xinming Li
Journal:  Cell Cycle       Date:  2019-03-20       Impact factor: 4.534

3.  MiRNA-130a promotes inflammation to accelerate atherosclerosis via the regulation of proliferator-activated receptor γ (PPARγ) expression.

Authors:  Fengtong Liu; Yali Liu; Yuqing Du; Youshan Li
Journal:  Anatol J Cardiol       Date:  2021-09       Impact factor: 1.596

Review 4.  Epigenetic Biomarkers in Cardiovascular Diseases.

Authors:  Carolina Soler-Botija; Carolina Gálvez-Montón; Antoni Bayés-Genís
Journal:  Front Genet       Date:  2019-10-09       Impact factor: 4.599

Review 5.  MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis.

Authors:  Emma L Solly; Catherine G Dimasi; Christina A Bursill; Peter J Psaltis; Joanne T M Tan
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

6.  Serum miRNA as a possible biomarker in the diagnosis of bipolar II disorder.

Authors:  Sheng-Yu Lee; Ru-Band Lu; Liang-Jen Wang; Cheng-Ho Chang; Ti Lu; Tzu-Yun Wang; Kuo-Wang Tsai
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.